{
    "Orphapacket": {
        "ORPHApacketId": "35069",
        "creationDate": "2020-12-03 15:53:15",
        "version": "1.3.6 / 4.1.7 [2020-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2020",
        "ORPHAcode": "35069",
        "Label": "Infantile neuroaxonal dystrophy",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_35069",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "INAD"
            },
            {
                "Synonym": "INAD1"
            },
            {
                "Synonym": "PLAN"
            },
            {
                "Synonym": "Phospholipase A2-associated neurodegeneration"
            },
            {
                "Synonym": "Seitelberger disease"
            }
        ],
        "ExternalReferences": [
            {
                "ExternalReference": {
                    "Source": "OMIM",
                    "Reference": "256600",
                    "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
                }
            },
            {
                "ExternalReference": {
                    "Source": "OMIM",
                    "Reference": "610217",
                    "DisorderMappingRelation": "BTNT (ORPHA code's Broader Term maps to a Narrower Term)"
                }
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Infantile neuroaxonal dystrophy/atypical neuroaxonal dystrophy (INAD/atypical NAD) is a type of neurodegeneration with brain iron accumulation (NBIA; see this term) characterized by psychomotor delay and regression increasing neurological involvement with symmetrical pyramidal tract signs and spastic tetraplegia. INAD may be classic or atypical and patients present with symptoms anywhere along a continuum between the two."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "PLA2G6",
                    "Name": "phospholipase A2 group VI",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "98497",
                        "Label": "Genetic peripheral neuropathy"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "329303",
                        "Label": "PLA2G6-associated neurodegeneration"
                    }
                ]
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0000496",
                    "HPOTerm": "Abnormality of eye movement",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000505",
                    "HPOTerm": "Visual impairment",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000639",
                    "HPOTerm": "Nystagmus",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000648",
                    "HPOTerm": "Optic atrophy",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001250",
                    "HPOTerm": "Seizures",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001252",
                    "HPOTerm": "Muscular hypotonia",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002376",
                    "HPOTerm": "Developmental regression",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0004326",
                    "HPOTerm": "Cachexia",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Infancy"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Neonatal"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}